Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib + SOX in advanced gallbladder carcinoma
NCT03702491Phase 2Unknown
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Aug 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in gallbladder carcinoma, sponsored by Eastern Hepatobiliary Surgery Hospital. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
gallbladder carcinoma
Beyond the preview
Go deeper on NCT03702491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702491.